Anticoagulants

Rx

VED

Tranexamic Acid Velpharm  

Tranexamic Acid Velpharm

Rx

VED

Active ingredient (INN)
tranexamic acid
Composition (active ingredients)
tranexamic acid - 50 mg
Фармакотерапевтическая группа
hemostatic agent - fibrinolysis inhibitor
Pharmacotherapeutic group
solution for intravenous administration 50 mg/ml 5 ml №10
Сonditions of supply
on prescription
Indications

Indications

  • menorrhagia and metrorrhagia;
  • gastrointestinal bleeding;
  • bleeding after surgery on the prostate and bladder;
  • bleeding during surgical interventions in the nasal cavity, mouth and pharynx (adenoidectomy, tonsillectomy, tooth extraction);
  • bleeding with thoracic, abdominal and other major surgical interventions (including cardiac surgery);
  • obstetric and gynecological bleeding (including bleeding during gynecological surgery);
  • bleeding caused by the use of fibrinolytic drugs.
Dosage regimen

Dosage regimen

Adult patients.

Treatment of menorrhagia and metrorrhagia, gastrointestinal bleeding

500 mg 2-3 times a day from the moment of bleeding until it stops

Treatment of bleeding after surgery on the prostate and urinary tract

1000 mg 3 times a day from the moment of bleeding until it stops

Prevention and treatment of bleeding during surgical interventions in the nasal cavity, mouth and pharynx

10-15 mg/ml body weight every 6-8 hours until the bleeding stops

Prevention and treatment of bleeding with thoracic, abdominal and other extensive surgical interventions

15 mg/kg body weight every 6-8 hours until bleeding stops

Prevention and treatment of bleeding during cardiac surgery

loading dose of 15 mg/kg after induction of anesthesia before surgery, then intravenous infusion at a rate of 4.5 mg/kg/hour throughout the operation; 0.6 mg/kg tranexamic acid is recommended for use in a heart-lung machine

Treatment of obstetric and gynecological bleeding (including bleeding during gynecological surgery)

15 mg/kg body weight every 6-8 hours from the moment of bleeding until it stops

Treatment of bleeding caused by the use of fibrinolytic drugs

10 mg/kg body weight every 6-8 hours from the moment of bleeding until it stops

Children over 1 year old

experience with tranexamic acid in children is limited. The recommended dose of the drug in the treatment of bleeding due to local and generalized fibrinolysis is 20 mg/kg/day

Patients with impaired renal function

in patients with mild to moderate impaired renal excretory function, dose and rate of administration of tranexamic acid should be adjusted

Impaired liver function

in patients with impaired liver function, dose adjustment is not required

Elderly patients

in elderly patients in the absence of renal failure, dose adjustment is not required

Contraindications

There are contraindications, consult with a specialist before use